FDA Investigator Diana M Rand
Diana M Rand has conducted inspections on 125 sites in 1 countries as of 05 Dec 2006. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
125
Last Inspection Date:
05 Dec 2006
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Diana M Rand:
Abby Lmozeke Baker,
Abby M Miller,
Aimee K Contreras,
Alan P Kurtzberg,
Alexandra B Pitkin,
Ana Djurdjevic,
Annette Melendez,
Anthony N Onianwa,
Arie C Menachem,
Armando Chavez, MS,
Bailey A Uetrecht,
Barbara J Rincon,
Belinda E Clifton,
Bichsa T Tran,
Binh T Nguyen,
Bonnie I Needleman,
Brian J Ryan,
Brian P Putz,
Brian Ravitch,
Bruce W Benware,
Bryce A May,
Carla J Lundi,
Carrie E Jolly,
Caryn M Everly,
Caryn M Mcnab,
Cathleen A Carr Sharpe,
Celena Ngo,
Celeta S Coves,
Charles D Boison,
Charles L Larson,
Chelsea N Sealey,
Cheryl D Mccall,
Christopher J Adams,
Christopher M Jenner,
Cori W Bitterman,
Courtney R Ingalsbe,
Daniel J Roberts,
Darla J Christopher,
Darren S Brown,
Darrin E Davis,
David G Whitman,
David P Vanhouten,
David Y Hernandez,
Davis,
Debra J Fracassa,
Dejon N Harris,
Derek S Dealy,
Desiree C Iya,
Devon Jenkins,
Diana L Ayala,
Diane Cvan Leeuwen,
Donna D Gallien, MPH,
Donna Ltartaglino Besone,
Durell L Giles,
Eileen T Dupont,
Emily S Mcgann,
Eric Zhu,
Erica R Mahone,
Erica R Woody,
Francisco,
Gabriel Craig,
Gabriel M Guevarra,
Garciam,
Garrad R Poole,
Gene D Arcy,
Geoffrey M Leist,
Geraldine M Peregrin,
Greg K Keshishyan,
Heika R Tait,
Henry E Carrillo,
Hung H Do, MS,
Irina Gaberman,
Jacob W Reynolds,
Jacobitz,
James A Barreto,
James P Stallings,
Jane G Choi,
Jeff M Uriarte,
Jeffery A Johnson,
Jennifer M Pouget,
Jinnie Kokiatkulkij,
Joanne M Fukuda,
Joey V Quitania,
John A Daubenspeck,
John A Liu,
John E Emmert,
Jonathan K Dare,
Joseph M Allen,
Joshua S Hoeh,
Judy C Nepsa,
Ka L Wong,
Kate L Allen,
Kelvin Cheung,
Kelvin X Sanders,
Kenneth R Merritt,
Kenneth S Boehnen,
Kevin Lee,
Kevin T Gerrity,
Kham Phommachanh,
Khoa Nathanv Tran,
Kim Lthomas Cruse,
Lacresha Menifee,
Lakecha N Lewis,
Laura A Munsterman,
Laurissa S Flowers,
LCDR Wilfred A Darang,
Lilly O Barton,
Linda F Murphy,
Linda Thai,
Lisa H Nakagawa,
Loretta J Miller,
Lucas B Leake,
Mageet,
Marcus F Yambot,
Margo C Jones,
Mark C Saale,
Mark E Imsland,
Mary C Wall,
Mary Ewilkerson Brinsko,
Matthew J Gretkierewicz,
Maxyne T Lam,
Mei Chen Mu,
Melissa D Kalik,
Melsomar R Ramos,
Michael D Garcia,
Michael E Cimaglio,
Michael S Call,
Michelle J Hines,
Minh D Phan,
Monica R Maxwell,
Myers,
Nancy E Byerly,
Natalie J Ayoub,
Natalie J Reese,
Nataniel Phillips Sylvain, PhD,
Naveen B Walker,
Ngoc T Le,
Nianna C Burns,
Nicholas Fragedakis,
Nicholas L Hunt,
Nikisha M Bolden,
Phal K Chhun,
Phillip L Toy,
Prabhu P Raju,
Rachel V Leimbach,
Randall N Johnson,
Raymond T Oji,
Raymond W Brullo,
Richard W Tubb,
Richmond K Yip,
Robert C Hoover,
Robert D Tollefsen,
Robert S Sweeton,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Rowena Trevino Solis,
Sabino S Camacho,
Sandra L Shire, DMD, MPA,
Sandra Sejdinovic,
Santiago Gallardo Johnson,
Sara Jdent Acosta,
Sarah A Hassas,
Sean P Desbrow,
Shaquenta Y Perkins,
Sheila Alaghemand,
Siobhan G Taylor,
Sonia R Peterson,
Sparky L Bartee,
Stephanie A Slater, MS,
Steven P Allen,
Sue Lee Chan,
Sundy V Sedwick,
Sydney S Taylor,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Tammy Vasquez Hancock,
Tania Y Hall,
Tawny L Colling,
Terrance L Thomas,
Terry L Boles,
Thanh M Andrews,
Thao T Kwan,
Thao X Tran,
Thomas C Mclean, CFS,
Thomas J Arista,
Timothy P Lafave,
Timothy T Kapsala,
Tonia L Sawyer,
Travis R Hunt,
Trushani T Desai,
Tuan D Tran,
Uttaniti Limchumroon (Tom),
Vanessa R Muller,
Vien Q Le,
Virgilio F Pacio, CSO,
Walden H Lee,
Whitney S Reynolds,
William J Leonard,
Wr Bowman,
Xavier M Rios,
Yvette Mlacour Davis,
Yvonne C Wilkes,
Zachary A Bogorad
Diana M Rand's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2004 | EIR | Revlon Consumer Products Corp - EIR, 2004-03-25 |
June, 2004 | FDA 483 Response | Life-flo Health Care Products - Form 483R, 2004-07-12 |
June, 2004 | FDA 483 | Seychelles Organic Inc - Form 483, 2004-06-17 |
September, 2002 | EIR | Saputo Cheese USA Inc - EIR, 2002-09-26 |
June, 2004 | FDA 483 | Life-flo Health Care Products - Form 483, 2004-06-17 |
September, 2002 | FDA 483 | Saputo Cheese USA Inc - Form 483, 2002-09-26 |
April, 2006 | FDA 483 | LICO Industries, LLC - Form 483, 2006-04-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more